PMDA drug package insert
アジルバ錠10mg
PMDA Prescription drug · 武田薬品工業株式会社 · package insert Sep 9, 2025
Key facts
| Brand names | アジルバ錠10mg, アジルバ錠20mg, アジルバ錠40mg, アジルバ顆粒1% |
|---|---|
| Nonproprietary names | アジルサルタン |
| Companies | 製造販売元／武田薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 持続性AT1レセプターブロッカー |
| Therapeutic category codes | 872149 |
| YJ codes | 2149048F3025, 2149048F1022, 2149048F2029, 2149048D1021 |
| Approval numbers | 22600AMX00521, 22400AMX00038, 22400AMX00039, 30300AMX00440 |
| Package insert edition | 第6版 |
| Package insert date | Sep 9, 2025 |
| PMDA document key | 400256_2149048F1022_1 |
| PMDA company code | 400256 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: